Some news
Dear colleagues, dear friends, dear Pneumotox users,I transferred the chairmanship of my department to retire only partly, still joyfully practicing as a consulting hospital-based pulmonary physician in our area.During the past years, an ever increasing but heterogenous body of literature on DIRD has emerged. This stays surveyed and critically evaluated daily, as it has been for over three decades. Since 2013, 5,400 new references were added to the bibliography section of Pneumotox through weekly updates. Large pharmacovigilance databases have shed some light of DIRD in real life. And AI may emerge as a significant servant and contributor in the daily approach of this topic.Beside survey of the literature, steering Pneumotox was and stays a daily and multifaceted challenge. As Pneumotox was built to be and stay free for all, funding is a durable challenge (a “wish to donate” link is now present on the frontpage). No least were issues related to technological advancements in computer and web science, requiring Pneumotox to be extensively overhauled to a new, more stable and more secure environment. Short of being upgraded or rebuilt, websites can get vulnerable in their weak spots. As you saw, technological obsolescence has shut down both Pneumotox and Cardiolox Apps. Apologies for that. The Apps have been carefully rebuilt and it is my pleasure to announce they are now back on track.Thank to a set of people at Akyos Communication in Dijon, Pneumotox data and files were merged, synched, transferred and are now secured in a safe backup. Pneumotox and Cardiotox websites had their graphic redesigned while staying inspired by the previous design, as a soft transition. Previous features were maintained as new ones were and are being developed. Both Pneumotox and Cardiotox Apps were rejuvenated, and are now back at your fingertips August 14, 2026 onward.As a safeguard, the previous version of Pneumotox is maintained and kept as a safe background resource, should there be any need.I will invite distinguished colleagues to join me in an International Pneumotox Monitoring Board, to ensure maintenance, development and advances of Pneumotox and iatrogenic science and funding.I encourage you to contact me, wishing Pneumotox will match your and my expectations in terms of quality, reliability and excellence for you all in the foreseable future.As ever before, alongside Pneumotox as a free and ad-free resource, I can swiftly answer personally any query 7/7.Thank you very much for your trust.My warmest regards.Philippe Camus MD